SCHEMBL320236

SCHEMBL320236

CC1(C)C=CCC(C)(C)N1O

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4555681 0.98
Hydrochloric Acid SCHEMBL4555680 0.95
SCHEMBL3622381 0.74 GAA (0.32) GAAL3MBTL1
Dropempine SCHEMBL1835367 0.72
SCHEMBL320235 0.70
SCHEMBL7159276 0.68
SCHEMBL563891 0.67 GAA (0.35) GAAL3MBTL1
SCHEMBL6657843 0.63
SCHEMBL13700736 0.62
SCHEMBL2380300 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200283918-A1 METHOD FOR PRODUCING LACTIC ACID NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2020-09-10 US claimed
EP-2125716-A2 HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE Othera Holding, Inc. (US) 2009-12-02 EP claimed
US-20080280890-A1 HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE COLBY PHARMACEUTICAL COMPANY 2008-11-13 US claimed
WO-2008103613-A2 HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE OTHERA HOLDING, INC. (US) 2008-08-28 WO claimed
EP-1674440-B1 Process for transition metal free catalytic aerobic oxidation of alcohols under mild conditions using stable free nitroxyl radicals EVONIK DEGUSSA GMBH (DE) 2008-05-07 EP claimed
EP-1674440-A1 Process for transition metal free catalytic aerobic oxidation of alcohols under mild conditions using stable free nitroxyl radicals Degussa GmbH (DE) 2006-06-28 EP claimed
EP-0866060-B1 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6,-tetramethylpyridin-N-oxyl DEGUSSA (DE) 2002-11-20 EP claimed
EP-0866060-A2 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6,-tetramethylpyridin-N-oxyl HÜLS AKTIENGESELLSCHAFT (DE) 1998-09-23 EP claimed
US-11976421-B2 Wet laid disposable absorbent structures with high wet strength and method of making the same FIRST QUALITY TISSUE, LLC (US) 2024-05-07 US disclosed
US-11952721-B2 Wet laid disposable absorbent structures with high wet strength and method of making the same FIRST QUALITY TISSUE, LLC (US) 2024-04-09 US disclosed
US-20230407575-A1 WET LAID DISPOSABLE ABSORBENT STRUCTURES WITH HIGH WET STRENGTH AND METHOD OF MAKING THE SAME JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2023-12-21 US disclosed
US-20230407573-A1 WET LAID DISPOSABLE ABSORBENT STRUCTURES WITH HIGH WET STRENGTH AND METHOD OF MAKING THE SAME JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2023-12-21 US disclosed
WO-2023245110-A1 WET LAID DISPOSABLE ABSORBENT STRUCTURES WITH HIGH WET STRENGTH AND METHOD OF MAKING THE SAME FIRST QUALITY TISSUE, LLC (US) 2023-12-21 WO disclosed
WO-2023244237-A1 WET LAID DISPOSABLE ABSORBENT STRUCTURES WITH HIGH WET STRENGTH AND METHOD OF MAKING THE SAME FIRST QUALITY TISSUE, LLC (US) 2023-12-21 WO disclosed
EP-0894790-A1 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6-tetramethylpyridine HÜLS AKTIENGESELLSCHAFT (DE) 1999-02-03 EP disclosed
EP-0866060-A3 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6,-tetramethylpyridin-N-oxyl HÜLS AKTIENGESELLSCHAFT (DE) 1998-10-21 EP disclosed
EP-0866060-A3 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6,-tetramethylpyridin-N-oxyl HÜLS AKTIENGESELLSCHAFT (DE) 1998-10-21 EP disclosed
EP-0866060-A2 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6,-tetramethylpyridin-N-oxyl HÜLS AKTIENGESELLSCHAFT (DE) 1998-09-23 EP disclosed
EP-0866060-A2 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6,-tetramethylpyridin-N-oxyl HÜLS AKTIENGESELLSCHAFT (DE) 1998-09-23 EP disclosed
EP-0866060-A2 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6,-tetramethylpyridin-N-oxyl HÜLS AKTIENGESELLSCHAFT (DE) 1998-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280890-A1 HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE HDGF, HMOX1, HMOX2 GAA 3200/4885L3MBTL1 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.